MedTrace Logo

Molecular Markers in Cervical Cancer Screening in the Feasibility of the Mathematical Markov Model Analysis

NCT00889902 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2009-04-29

No results posted yet for this study

Summary

The purpose of this study is to:

1. make p16INK4A as a cervical cancer screening of tumor markers, cytology improve existing diagnostic sensitivity, specificity, repeatability and validity, so as to effectively prompted the early discovery and diagnosis of cervical cancer.
2. reduce screening costs, screening and benefits into quantitative evaluation, for our country to develop cervical cancer prevention and control strategy to provide a reliable theoretical basis.

Conditions

Sponsors & Collaborators

  • Wuhan University

    lead OTHER

Principal Investigators

  • Hong B Cai, Doctor · gynecologic oncology department, Zhongnan Hospital of Wuhan University

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2010-06-30
Completion
2011-07-31

Countries

  • China

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00889902 on ClinicalTrials.gov